| Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
---|
Cash and cash equivalents | 2 | - | 1 | 1 | 434,571 | 124,637 | 282,154 | 197,356 | 36,363 | 135,309 | 5 | 2 |
---|
Accounts receivable, net | 11 | - | 5 | 8 | 8 | 7 | 12 | 1 | 24,840 | 7 | 7 | 3 |
---|
Advances to suppliers | - | - | - | - | - | - | - | - | - | - | - | 7 |
---|
Inventories, net | 581,176 | - | 3 | 6 | 7 | 5 | 2 | 937,966 | 707,526 | 735,351 | 3 | 8 |
---|
Prepayments and other receivables | 2 | - | 1 | 864,317 | 2 | 3 | 4 | 131,442 | 59,333 | 15 | 3 | 1 |
---|
Current assets from discontinued operations-held for sale | - | - | - | - | - | - | - | - | - | - | - | 2 |
---|
Total current assets | 17 | - | 12 | 19 | 20 | 15 | 19 | 3 | 22 | 25 | 21 | 23 |
---|
Deferred tax assets | - | - | - | - | - | - | - | - | - | 193,211 | 207,549 | 190,132 |
---|
Property, plant and equipment, net | 11 | - | 15 | 14 | 11 | 17 | 20 | 18 | - | - | 4 | 2 |
---|
Intangible assets, net | 3 | - | - | - | - | - | - | - | 8 | - | 18,039 | 16,183 |
---|
Operating lease-right of use assets | - | - | - | - | - | - | - | - | - | - | 5 | 3 |
---|
Goodwill | - | - | - | - | - | - | - | - | - | 7 | 8 | 2 |
---|
Total long-term investment | - | - | - | - | - | - | - | - | - | - | - | 2 |
---|
Non-current assets from discontinued operations-held for sale | - | - | - | - | - | - | - | - | - | - | - | 4 |
---|
Total non-current assets | 26 | - | 30 | 29 | 25 | 22 | 23 | 20 | 8 | 8 | 17 | 12 |
---|
TOTAL ASSETS | 44 | - | 43 | 48 | 44 | 37 | 41 | 23 | 30 | 33 | 38 | 36 |
---|
Short-term loans | 7 | - | 7 | 8 | 8 | 6 | 7 | 6 | - | 904,228 | 2 | 818,425 |
---|
Long-term loans due within one year | - | - | - | - | - | - | - | - | - | 34,201 | 369,187 | 105,965 |
---|
Convertible promissory notes, net | - | - | - | - | - | - | - | - | - | - | 5 | 1 |
---|
Accounts payable, trade | 3 | - | 1 | 6 | 5 | 3 | 4 | 3 | 641,927 | 6 | 7 | 11 |
---|
Advances from customers | - | - | - | - | - | - | - | - | - | - | 2 | 923,131 |
---|
Amount due to related parties | 431,682 | - | 431,682 | 431,682 | 431,682 | 431,682 | 431,682 | 918,033 | 305,760 | 226,514 | 730,285 | 5 |
---|
Taxes payable | - | - | - | - | - | - | - | - | 861 | 773,649 | 662,777 | 71,915 |
---|
Other payables and accrued liabilities | - | - | - | - | - | - | - | - | - | - | - | 3 |
---|
Lease liability-current | - | - | - | - | - | - | - | - | - | 23,063 | 954,182 | 532,630 |
---|
Current liabilities from discontinued operations-disposal | - | - | - | - | - | - | - | - | 13 | - | - | - |
---|
Current liabilities from discontinued operations-held for sale | - | - | - | - | - | - | - | - | - | - | - | 3 |
---|
Total current liabilities | 13 | - | 11 | 17 | 14 | 11 | 14 | 13 | 22 | 16 | 22 | 25 |
---|
Lease liability-non current | - | - | - | - | - | - | - | - | - | 22,457 | 4 | 3 |
---|
Long-term loans - non-current | - | - | - | - | - | - | - | - | - | 720,997 | 538,006 | 314,786 |
---|
Non-current liabilities from discontined operations-held for sale | - | - | - | - | - | - | - | - | - | - | - | 2 |
---|
TOTAL LIABILITIES | 14 | - | 11 | 17 | 14 | 11 | 14 | 13 | 22 | 16 | 27 | 30 |
---|
Common stock, $0.001 par value; 200,000,000 shares authorized; 3,764,780 and 850,222 shares issued and outstanding as of December 31, 2022 and 2021, respectively* | 5,326 | - | 5,619 | 5,719 | 6,553 | 7,073 | 7,073 | 7,573 | 9,073 | 13,254 | 8,502 | 3,765 |
---|
Additional paid-in capital | - | - | - | - | - | - | - | - | - | - | - | 72 |
---|
Statutory reserves | - | - | - | - | - | - | - | - | - | - | - | 2 |
---|
Accumulated deficit | - | - | - | - | - | - | - | - | - | - | - | -70,143,785 |
---|
Accumulated other comprehensive income | 3 | - | 5 | 5 | 3 | 858,502 | 3 | 2 | 2 | 1 | 2 | 24,583 |
---|
Total BIMI International Medical Inc.’s equity | 30 | - | 32 | 31 | 30 | 27 | 27 | 10 | 9 | 17 | 11 | 5 |
---|
NON-CONTROLLING INTERESTS | - | - | - | - | - | - | 49,044 | -150,311 | -170,050 | 183,021 | 142,997 | 1 |
---|
Total stockholders’ equity | - | - | - | - | - | - | 27 | 10 | 9 | 17 | 11 | 5 |
---|
Total liabilities and stockholders’ equity | 44 | - | 43 | 48 | 44 | 37 | 41 | 23 | 30 | 33 | 38 | 36 |
---|